Exclusive: Pfizer begins to export U.S.-made COVID-19 shots, first doses sent to Mexico
FILE PHOTO: A person walks past a Pfizer logo amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., April 1, 2021. REUTERS/Carlo Allegri reuters tickers
This content was published on April 30, 2021 - 02:26
April 30, 2021 - 02:26
By Carl O Donnell
(Reuters) - Pfizer Inc s shipment of COVID-19 vaccine to Mexico this week includes doses made in its U.S. plant, the first of what are expected to be ongoing exports of its shots from the United States, a source familiar with the matter told Reuters on Thursday.
By Farah Master HONG KONG (Reuters) - In Hong Kong s famed party zone Lan Kwai Fong, dormant bars and clubs are revving up to serve customers again, but only if they have had at least one vaccine shot - one of the few examples globally of offering greater freedom for the vaccinated. Bar staff need to have gotten at least one coronavirus vaccine dose too, and patrons must register with a government mobile tracking application as they enter. The Chinese special administrative region has kept COVID-19 transmission largely under control. Hong Kong has recorded more than 11,700 coronavirus cases, far lower than other developed cities. The new rules come as authorities there try to encourage the city s 7.5 million residents to get vaccinated; only about 12% have received their first dose. The re-opening of bars and the extension of opening hours are incentives for people to receive the vaccination, while the most important thing . is to prevent the spread of the infection, should it hit us a
Quality or speed? Scientists face Covid-19 dilemma
There was a heated debate in parliament about whether only Martin Ackermann, president of the National Covid-19 Science Taskforce, should be allowed to speak publicly about Covid-19. In the end parliament decided against this. Keystone / Peter Schneider
The Covid-19 pandemic has pushed science and research to the fore. But the unprecedented influence it currently wields over politics and public life has a downside: the crisis demands quick answers that risk scientists’ credibility.
This content was published on April 29, 2021 - 09:00
April 29, 2021 - 09:00
Christian Raaflaub
“Since the start of the pandemic there has been a veritable tsunami of scientific publications about Sars-CoV-2,” says Subhra Priyadarshini, editor-in-chief of
Vaccines cut household COVID-19 transmission by up to a half, English data shows
FILE PHOTO: A dose of AstraZeneca vaccine is prepared at COVID-19 vaccination centre in the Odeon Luxe Cinema in Maidstone, Britain February 10, 2021. REUTERS/Andrew Couldridge reuters tickers
This content was published on April 28, 2021 - 07:43
April 28, 2021 - 07:43
LONDON (Reuters) -COVID-19 vaccines deployed in England can cut transmission of the coronavirus in households by up to a half, data from Public Health England (PHE) showed on Wednesday, in addition to the protection the shots offer against symptomatic infection.
The research offers insight on one of the big unknowns over COVID-19 vaccinations - the extent to which they prevent transmission of the coronavirus - and could strengthen the case for Prime Minister Boris Johnson plans to end England s lockdown in June.